 Name: ___           Unit No:  ___  Admission Date: ___       Discharge Date:  ___  Date of Birth: ___       Sex:  F  Service: SURGERY  Allergies: No Known Allergies / Adverse Drug Reactions  Attending: ___.  Chief Complaint: Nausea, UTI

 Major Surgical or Invasive Procedure: None  History of Present Illness: HPI: Ms. ___ is a ___ year-old woman who was recently discharged after a completion pancreatectomy and splenectomy on ___ who presents 5 days after diagnosis of UTI with continued elevated blood sugars, nausea, fatigue and weight loss.

She was doing well after returning home but 5 days ago began to develop fatigue and uncontrolled blood sugars. PCP obtained UA which was positive and she was initiated on Macrobid at that time. However, she has not improved in terms of her fatigue and nausea. She called in during the day and we suggested evaluation at nearby urgent care, and she was subsequently transferred to ___ for further evaluation. 

On arrival, vitals were stable and she is in no acute distress. She has mild nausea. She denies changes in urinary or bowel habits. She denies chest pain or shortness of breath, and denies abdominal pain. 

 Past Medical History: Past Medical History: 1. DCIS of the left breast, diagnosed in ___. She underwent lumpectomy with multifocal disease found, with a subsequent completion mastectomy and autologous reconstruction. She received no adjuvant therapy or hormone therapy.  2. GERD.  3. Migraines.  4. Diverticulitis.  5. Pancreatic adenocarcinoma. 

PAST SURGICAL HISTORY:  - ___ - radical pancreaticoduodenectomy (including pancreatic neck and proximal body) with en bloc resection of SMV/splenic vein/portal vein with reconstruction using left internal jugular vein - ___ - completion pancreatectomy and splenectomy - left mastectomy, reconstruction with TRAM flap - colonoscopy - colporrhaphy - exploratory laparoscopy - portacath placement  Social History: ___ Family History: Family History: Significant for a cousin with breast cancer, otherwise no history of malignancy.

 Physical Exam: Physical Exam: Temp: 98.3 PO BP: 127/79 L Lying HR: 68 RR: 18 O2 sat: 99% O2 delivery: RA GEN: A&O x 3, NAD HEENT: no scleral icterus CV: RRR, no m/r/g PULM: CTAB ABD: Nontender, non-distended. Midline incision open to air with staples and c/d/I EXTR: Warm, no c/c/e

 Pertinent Results: ___ 04:32PM BLOOD WBC-10.8* RBC-3.12* Hgb-8.9* Hct-27.9* MCV-89 MCH-28.5 MCHC-31.9* RDW-18.9* RDWSD-61.9* Plt ___ ___ 04:32PM BLOOD Neuts-69.6 Lymphs-12.8* Monos-13.3* Eos-3.1 Baso-0.8 NRBC-0.2* Im ___ AbsNeut-7.52* AbsLymp-1.38 AbsMono-1.43* AbsEos-0.33 AbsBaso-0.09* ___ 04:32PM BLOOD Glucose-245* UreaN-13 Creat-0.5 Na-132* K-4.9 Cl-93* HCO3-24 AnGap-15 ___ 04:32PM BLOOD ALT-8 AST-13 AlkPhos-105 TotBili-0.4 ___ 04:32PM BLOOD Albumin-3.9 Calcium-9.4 Phos-3.6 Mg-2.0

CT abd pelvis, ___

IMPRESSION: 1. Irregular-shaped fluid collection tracking along the medial edge of the liver, surrounding the intrahepatic IVC, and extending into the portal hepatis. The fluid collection measures approximately 5.8 x 4.2 in the superior component and 5.3 x 2.0 cm in the inferior component surrounding intrahepatic IVC and spanning approximately 9.0 cm craniocaudally. This likely reflects a postoperative seroma, but please note that infection of this fluid collection cannot be excluded on the basis of this imaging exam. 2. Postoperative changes in the central abdomen post pancreatectomy and splenectomy. 3. New mesenteric lymphadenopathy inferior to the surgical bed which may be reactive. Continued surveillance is advised. 4. Pneumobilia as expected from hepaticojejunostomy. 

 Brief Hospital Course: The patient presented to ED on ___ with nausea and lethargy and dysuria. Initial CT of abdomen and pelvis showed a seroma but it was consistent with expected post-operative changes. Patient was admitted to our service. ___ and ID were consulted to help with adequate management of her UTI as well as her glucose control. ___ recommended to increase lantus from 6 to 8; and increase Humalog base dose to 4 and increase by 1 unit for every 50 pts above 150; they reviewed it with pt and family and scheduled f/u at ___. Patient was on MAcrobid for 5 days with no resolution of dysuria, ID recommended switching to po ciproflox ABx for 10 days. #NEURO: The patient was alert and oriented throughout hospitalization; pain was very well controlled.  #CV: The patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored.  #PULMONARY: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. Good pulmonary toilet, ambulation and incentive spirometry were encouraged throughout hospitalization.  #GI/GU/FEN: The patient was tolerating a regular diet. Patient urine output was appropriate. #ID: The patient's fever curves were closely watched for signs of infection, of which there were none.  #HEME: Patient received BID SQH for DVT prophylaxis, in addition to encouraging early ambulation and Venodyne compression devices.  At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating diet as above per oral, ambulating, voiding, and pain was well controlled. The patient was discharged home on Antibiotics. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. 

 Medications on Admission: insulin glargine [Basaglar KwikPen U-100 Insulin], lipase-protease-amylase [Creon], insulin aspart U-100 [Novolog Flexpen U-100 Insulin], blood sugar diagnostic [OneTouch Verio], acetaminophen, aspirin, blood-glucose meter, blood-glucose meter, enoxaparin, lancets, omeprazole, ondansetron, pen needle, diabetic, prochlorperazine maleate, ranitidine HCl, Lovenox  Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever  2. Ciprofloxacin HCl 500 mg PO Q12H RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*18 Tablet Refills:*0 3. Creon 12 3 CAP PO TID W/MEALS  4. Enoxaparin Sodium 40 mg SC DAILY Start: ___, First Dose: Next Routine Administration Time  5. Glargine 8 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 6. Omeprazole 20 mg PO DAILY  7. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Moderate 

 Discharge Disposition: Home  Discharge Diagnosis: UTI, hyperglycemia  Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent.  Discharge Instructions: Ms. ___,

You were admitted to the surgery service at ___ for blood glucose management and treatment of your urinary tract infection. You have done well in the post operative period and are now safe to return home to complete your recovery with the following instructions: . Please call Dr. ___ office at ___ or Office RNs at 

___ if you have any questions or concerns. . Please continue with ___ recommendations, follow up with ___ as scheduled. . General Discharge Instructions:

Please resume all regular home medications , unless specifically 

advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. Avoid driving or operating heavy machinery while taking pain medications. Please follow-up with your surgeon and Primary Care Provider (PCP) as advised. . Incision Care: *Please call your doctor or nurse practitioner if you have increased pain, swelling, redness, or drainage from the incision 

site. *Avoid swimming and baths until your follow-up appointment. *You may shower, and wash surgical incisions with a mild soap and warm water. Gently pat the area dry. *If you have staples, they will be removed at your follow-up appointment.

 Followup Instructions: ___ 